- Home
- NYMT vs DNA Comparison
NYMT vs DNA Comparison
Compare NYMT & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYMT
- DNA
- Stock Information
- Founded
- NYMT 2003
- DNA 2008
- Country
- NYMT United States
- DNA United States
- Employees
- NYMT N/A
- DNA N/A
- Industry
- NYMT Real Estate Investment Trusts
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NYMT Real Estate
- DNA Health Care
- Exchange
- NYMT Nasdaq
- DNA Nasdaq
- Market Cap
- NYMT 538.5M
- DNA 478.8M
- IPO Year
- NYMT 2004
- DNA N/A
- Fundamental
- Price
- NYMT $5.43
- DNA $7.85
- Analyst Decision
- NYMT Buy
- DNA Sell
- Analyst Count
- NYMT 5
- DNA 5
- Target Price
- NYMT $7.13
- DNA $17.25
- AVG Volume (30 Days)
- NYMT 879.3K
- DNA 1.6M
- Earning Date
- NYMT 04-30-2025
- DNA 05-08-2025
- Dividend Yield
- NYMT 14.72%
- DNA N/A
- EPS Growth
- NYMT N/A
- DNA N/A
- EPS
- NYMT N/A
- DNA N/A
- Revenue
- NYMT $143,242,000.00
- DNA $227,043,000.00
- Revenue This Year
- NYMT N/A
- DNA N/A
- Revenue Next Year
- NYMT $20.60
- DNA $16.85
- P/E Ratio
- NYMT N/A
- DNA N/A
- Revenue Growth
- NYMT N/A
- DNA N/A
- 52 Week Low
- NYMT $5.01
- DNA $5.00
- 52 Week High
- NYMT $7.25
- DNA $45.20
- Technical
- Relative Strength Index (RSI)
- NYMT 32.50
- DNA 53.59
- Support Level
- NYMT $5.30
- DNA $7.93
- Resistance Level
- NYMT $5.61
- DNA $8.58
- Average True Range (ATR)
- NYMT 0.33
- DNA 0.81
- MACD
- NYMT -0.07
- DNA 0.36
- Stochastic Oscillator
- NYMT 26.92
- DNA 77.24
About NYMT New York Mortgage Trust Inc.
New York Mortgage Trust Inc is a real estate investment trust for federal income tax purposes, in the business of acquiring, investing in, financing and managing mortgage-related and residential housing-related assets. The company's investment portfolio consists of Structured multi-family property investments such as multi-family CMBS an preferred equity in, and mezzanine loans to owners of multi-family properties. Distressed residential assets such as residential mortgage loans sourced from distressed markets and non-Agency RMBS. Second mortgages, Agency RMBS, and certain other mortgage-related and residential housing-related assets.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.